Original Research
Published on 26 Oct 2022
Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer
in Drugs Outcomes Research and Policies
- 2,939 views
- 8 citations
Original Research
Published on 26 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 26 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 26 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 25 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 24 Oct 2022
in Drugs Outcomes Research and Policies
Systematic Review
Published on 24 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 21 Oct 2022
in Drugs Outcomes Research and Policies
Systematic Review
Published on 20 Oct 2022
in Drugs Outcomes Research and Policies
Brief Research Report
Published on 20 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 17 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 17 Oct 2022
in Drugs Outcomes Research and Policies
Review
Published on 14 Oct 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 14 Oct 2022
in Drugs Outcomes Research and Policies
Systematic Review
Published on 14 Oct 2022
in Drugs Outcomes Research and Policies